At ESMO 2014, Prof Tom Powles (Barts Cancer Institute, UK) discusses strategies in the management of kidney cancer. Recent clinical…
Browsing: Acute Lymphoblastic Leukemia
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr David Avigan (Harvard Medical School, Boston, MA) discusses recent…
Prof Claire Harrison (Guys and St Thomas NHS Foundation Trust, London, UK) discusses highlights on myeloproliferative neoplasms (MPNs) from the…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Denis-Claude Roy (University of Montreal, Montreal, Canada) discusses a…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Keith Stewart (Mayo Clinic, Scottsdale, AZ) discusses recent advances…
Stromal tumor-infiltrating lymphocytes(S-TILs): In the alliance N9831 trial S-TILs are associated with chemotherapy benefit but not associated with trastuzumab benefit
SABCS 2014: ECOG 1199 Trial Commentary by Dr. Sunil Verma: Ten year update of E1199: Phase III study of doxorubicin-cyclophosphamide…
SABCS 2014: TNT Trial Commentary by Dr. Sunil Verma: A randomized phase III trial of carboplatin (C) compared with docetaxel…
SABCS 2014: SOFT Trial Commentary by Dr. Sunil Verma: Randomized comparison of adjuvant tamoxifen (T) plus ovarian function suppression (OFS)…
The FERGI phase II study of the PI3K inhibitor pictilisib (GDC-0941) plus fulvestrant vs fulvestrant plus placebo in patients with…
A randomized phase III trial comparing neoadjuvant chemotherapy with weekly nanoparticle-based paclitaxel with solventbased paclitaxel followed by anthracyline/ cyclophosphamide for…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Catherine Bollard (Children’s National Medical Center, Washington, DC), Dr…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Stephan Grupp (Children’s Hospital of…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Joseph Alvarnas (City of Hope…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Craig Moskowitz (Memorial Sloan Kettering…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr David Steensma (Dana-Farber Cancer Institute, Boston, MA), Dr Brent…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Farhad Ravandi (The University of…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Eytan Stein (Memorial Sloan-Kettering Cancer…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Oliver Ottmann (Goethe-University Hospital, Frankfurt,…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Christoph Röllig (Universitätsklinikum Dresden, Dresden,…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Wendy Stock (University of Chicago…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Brent Wood (University of Washington,…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Nicola Gökbuget (University Hospital Frankfurt,…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Craig Moskowitz (Memorial Sloan Kettering…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Brad Kahl (University of Wisconsin School of Medicine, Madison,…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Philippe Armand (Dana-Farber Cancer Institute,…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Thomas Martin (University of California…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr MarÃa-Victoria Mateos (Hospital Universitario de…
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Keith Stewart (Mayo Clinic, Scottsdale,…
Dr Hans Hammers (Johns Hopkins, MD) discusses highlights from the Thirteenth International Kidney Cancer Symposium. Immunotherapies have received significant interest:…
At the Thirteenth International Kidney Cancer Symposium, Dr James Brugarolas (University of Texas Southwestern Medical Center, TX) discusses the clinical…
At the Thirteenth International Kidney Cancer Symposium, Dr James Hsieh (Memorial Sloan-Kettering Cancer Center, NY) discusses the progress in cancer…
At the Thirteenth International Kidney Cancer Symposium, Dr James Hsieh (Memorial Sloan-Kettering Cancer Center, NY) discusses the need for clinical…
At the Thirteenth International Kidney Cancer Symposium, Dr JianJun Gao (The University of Texas MD Anderson Cancer Center, TX) discusses…
At the Thirteenth International Kidney Cancer Symposium, Dr Abraham Ari Hakimi (Memorial Sloan-Kettering Cancer Center, NY) discusses recent developments in…
At the Thirteenth International Kidney Cancer Symposium, Dr Laurence Albiges (Gustave Roussy, France) provides an overview of papillary renal cell…
At the Thirteenth International Kidney Cancer Symposium, Dr Toni Choueiri (Dana-Farber Cancer Institute and Harvard Medical School, MA) discusses the…
At the Thirteenth International Kidney Cancer Symposium, Prof David Kwiatkowski (Brigham and Women’s Hospital, MA) discusses targeting the mTOR pathway…
At the Thirteenth International Kidney Cancer Symposium, Dr James Hsieh (Memorial Sloan-Kettering Cancer Center, NY) discusses chromophobe renal cell carcinoma…
At the Thirteenth International Kidney Cancer Symposium, Dr JianJun Gao (University of Texas MD Anderson Cancer Center, TX) provides an…
At the Thirteenth International Kidney Cancer Symposium, Dr Hans Hammers (Johns Hopkins, MD) encourages kidney cancer patients to take an…
At the Thirteenth International Kidney Cancer Symposium, Dr Hans Hammers (Johns Hopkins, MD) discusses the Phase 1 clinical trial that…
At the Thirteenth International Kidney Cancer Symposium, Dr Elizabeth Plimack (Fox Chase Cancer Center, PA) discusses highlights from the Thirteenth…
At the Thirteenth International Kidney Cancer Symposium, Dr Elizabeth Plimack (Fox Chase Cancer Center, PA) discusses prospective immunotherapy in kidney…
At the Thirteenth International Kidney Cancer Symposium, Dr Sumanta Pal (City of Hope Comprehensive Cancer Center, CA) discusses his research…
At the Thirteenth International Kidney Cancer Symposium, Dr Toni Choueiri (Dana-Farber Cancer Institute and Harvard Medical School, MA) provides an…
At the Thirteenth International Kidney Cancer Symposium, Dr Abraham Ari Hakimi (Memorial Sloan-Kettering Cancer Center, NY) discusses the current understanding…
At the Thirteenth International Kidney Cancer Symposium, Carolyn Konosky (Kidney Cancer Association, IL) encourages kidney cancer patients to have an…
At the Thirteenth International Kidney Cancer Symposium, Carolyn Konosky (Kidney Cancer Association, IL) provides an overview of the Kidney Cancer…
Latest Lung Cancer Updates from ESMO 2014 – Chemotherapy Advances by Dr. Sunil Verma